ACAM2000
From Infogalactic: the planetary knowledge core
| Vaccine description | |
|---|---|
| Target disease | Smallpox |
| Type | ? |
| Clinical data | |
| AHFS/Drugs.com | entry |
| Pregnancy category |
|
| Legal status |
|
| Identifiers | |
| ATC code | none |
ACAM2000 is a smallpox vaccine developed by Acambis. It was approved for use in the United States by the U.S. Food and Drug Administration (FDA) on 31 August 2007. It contains live vaccinia virus, cloned from the same strain used in an earlier vaccine, Dryvax. While the Dryvax virus was cultured in the skin of calves and freeze-dried, ACAM2000s virus is cultured in kidney epithelial cells (Vero cells) from an African green monkey. Efficacy and adverse reaction incidence are similar to Dryvax.[1] The vaccine is not routinely available to the US public; it is, however, used in the military and maintained in the Strategic National Stockpile.[2]
References
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ FDA/CBER Questions and Answers; Medication Guide; accessed 1 March 2008.
External links
<templatestyles src="Asbox/styles.css"></templatestyles>
Categories:
- Use dmy dates from July 2013
- Drugs that are a vaccine
- Chemicals that do not have a CAS Registry Number assigned
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs not assigned an ATC code
- Articles containing unverified chemical infoboxes
- Vaccines
- Smallpox
- Pages with broken file links
- Vaccine stubs
